Phathom Pharmaceuticals Earnings Estimate

PHAT Stock  USD 4.41  0.19  4.50%   
The next projected EPS of Phathom Pharmaceuticals is estimated to be -1.06 with future projections ranging from a low of -1.13 to a high of -1.02. Phathom Pharmaceuticals' most recent 12-month trailing earnings per share (EPS TTM) is at -5.29. Please be aware that the consensus of earnings estimates for Phathom Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Phathom Pharmaceuticals is projected to generate -1.06 in earnings per share on the 31st of March 2025. Phathom Pharmaceuticals earnings estimates show analyst consensus about projected Phathom Pharmaceuticals EPS (Earning Per Share). It derives the highest and the lowest estimates based on Phathom Pharmaceuticals' historical volatility. Many public companies, such as Phathom Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Phathom Pharmaceuticals' earnings estimates, investors can diagnose different trends across Phathom Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about 49.6 M in 2025, whereas Pretax Profit Margin is likely to drop (6.35) in 2025.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phathom Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Phathom Stock please use our How to Invest in Phathom Pharmaceuticals guide.

Phathom Pharmaceuticals Earnings Estimation Breakdown

The calculation of Phathom Pharmaceuticals' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Phathom Pharmaceuticals is estimated to be -1.06 with the future projection ranging from a low of -1.13 to a high of -1.02. Please be aware that this consensus of annual earnings estimates for Phathom Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-1.05
-1.13
Lowest
Expected EPS
-1.06
-1.02
Highest

Phathom Pharmaceuticals Earnings Projection Consensus

Suppose the current estimates of Phathom Pharmaceuticals' value are higher than the current market price of the Phathom Pharmaceuticals stock. In this case, investors may conclude that Phathom Pharmaceuticals is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Phathom Pharmaceuticals' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
992.13%
-1.05
-1.06
-5.29

Phathom Pharmaceuticals Earnings per Share Projection vs Actual

Actual Earning per Share of Phathom Pharmaceuticals refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Phathom Pharmaceuticals predict the company's earnings will be in the future. The higher the earnings per share of Phathom Pharmaceuticals, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Phathom Pharmaceuticals Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Phathom Pharmaceuticals, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Phathom Pharmaceuticals should always be considered in relation to other companies to make a more educated investment decision.

Phathom Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Phathom Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-03-05
2024-12-31-1.08-1.050.03
2024-11-07
2024-09-30-1.49-1.320.1711 
2024-08-08
2024-06-30-1.38-1.56-0.1813 
2024-05-09
2024-03-31-1.31-1.42-0.11
2024-03-07
2023-12-31-1.08-1.39-0.3128 
2023-11-09
2023-09-30-0.89-0.760.1314 
2023-08-10
2023-06-30-0.98-0.840.1414 
2023-05-10
2023-03-31-1.26-0.890.3729 
2023-02-28
2022-12-31-1.35-1.330.02
2022-11-08
2022-09-30-1.32-1.320.0
2022-08-02
2022-06-30-1.03-1.33-0.329 
2022-05-10
2022-03-31-0.97-1.07-0.110 
2022-03-01
2021-12-31-1.03-0.950.08
2021-11-08
2021-09-30-0.98-0.980.0
2021-08-10
2021-06-30-1.07-1.00.07
2021-05-11
2021-03-31-1.19-0.960.2319 
2021-03-30
2020-12-31-1.01-1.58-0.5756 
2020-11-10
2020-09-30-0.67-1.02-0.3552 
2020-08-06
2020-06-30-0.56-0.64-0.0814 
2020-05-12
2020-03-31-0.72-0.620.113 
2020-03-19
2019-12-31-1.25-3.97-2.72217 
2019-11-24
2019-09-30-1.14-9.3-8.16715 

About Phathom Pharmaceuticals Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Phathom Pharmaceuticals earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Phathom Pharmaceuticals estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Phathom Pharmaceuticals fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-1.3 B-1.2 B
Retained Earnings Total Equity-476.4 M-500.3 M
Earnings Yield(0.65)(0.68)
Price Earnings Ratio(1.53)(1.61)
Price Earnings To Growth Ratio(0.04)(0.04)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Phathom Stock Analysis

When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.